Literature DB >> 31280079

Conceptualizing comorbid PTSD and depression among treatment-seeking, active duty military service members.

John C Moring1, Erica Nason2, Willie J Hale3, Jennifer Schuster Wachen4, Katherine A Dondanville5, Casey Straud5, Brian A Moore3, Jim Mintz6, Brett T Litz7, Jeffrey S Yarvis8, Stacey Young-McCaughan5, Alan L Peterson9, Patricia A Resick10.   

Abstract

BACKGROUND: Among active duty service members and veterans with PTSD, depression is the most commonly diagnosed comorbid psychiatric condition. More research is warranted to investigate the relationship between PTSD and depression to improve treatment approaches. Byllesby et al. (2017) used confirmatory factor analyses in a sample of trauma-exposed combat veterans with PTSD and found that only the general distress factor, and not any specific symptom cluster of PTSD, predicted depression. This study seeks to replicate Byllesby et al. (2017) in a sample of treatment-seeking active duty soldiers.
METHODS: Confirmatory factor analyses, bifactor modeling, and structural equation modeling (SEM) were used with data gathered at pretreatment and posttreatment as part of a large randomized clinical trial.
RESULTS: Confirmatory factor analyses and bifactor modeling demonstrated that PTSD symptom clusters, Negative Alterations in Cognition and Mood (NACM) and Alterations in Arousal and Reactivity (AAR), as well as the general distress factor significantly predicted depression at pretreatment and posttreatment. LIMITATIONS: The current study was predominantly male, limiting the generalizability to female service members with PTSD. Also, self-report measures were used, which may introduce response-bias.
CONCLUSIONS: The current study did not replicate Byllesby et al. (2017). Results demonstrated that the relationship between PTSD and depression among active duty service members can be explained by both transdiagnostic factors and disorder-specific symptoms.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bifactor modeling; Confirmatory factor analyses; Depression; Military; Posttraumatic stress disorder

Mesh:

Year:  2019        PMID: 31280079      PMCID: PMC6750963          DOI: 10.1016/j.jad.2019.06.039

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  47 in total

1.  Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.

Authors:  Charles W Hoge; Carl A Castro; Stephen C Messer; Dennis McGurk; Dave I Cotting; Robert L Koffman
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

2.  The nature and course of subthreshold PTSD.

Authors:  Judith Cukor; Katarzyna Wyka; Nimali Jayasinghe; Joann Difede
Journal:  J Anxiety Disord       Date:  2010-06-25

3.  The factor structure of Posttraumatic Stress Disorder symptoms among bereaved individuals: a confirmatory factor analysis study.

Authors:  Paul A Boelen; Marcel A van den Hout; Jan van den Bout
Journal:  J Anxiety Disord       Date:  2008-02-07

4.  Role of occupation on new-onset post-traumatic stress disorder and depression among deployed military personnel.

Authors:  Jonathan A Mayo; Andrew J MacGregor; Amber L Dougherty; Michael R Galarneau
Journal:  Mil Med       Date:  2013-09       Impact factor: 1.437

5.  Integrated Cognitive Behavioral Therapy Versus Cognitive Processing Therapy for Adults With Depression, Substance Use Disorder, and Trauma.

Authors:  Moira Haller; Sonya B Norman; Kevin Cummins; Ryan S Trim; Xiaomin Xu; Ruifeng Cui; Carolyn B Allard; Sandra A Brown; Susan R Tate
Journal:  J Subst Abuse Treat       Date:  2015-11-26

6.  Rape survivors' trauma-related beliefs before and after Cognitive processing therapy: associations with PTSD and depression symptoms.

Authors:  Katherine M Iverson; Matthew W King; Katherine C Cunningham; Patricia A Resick
Journal:  Behav Res Ther       Date:  2015-01-29

7.  Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms.

Authors:  Domin Chan; Allen D Cheadle; Gayle Reiber; Jürgen Unützer; Edmund F Chaney
Journal:  Psychiatr Serv       Date:  2009-12       Impact factor: 3.084

8.  Changes in posttraumatic stress disorder and depressive symptoms during cognitive processing therapy: evidence for concurrent change.

Authors:  Gabrielle I Liverant; Michael K Suvak; Suzanne L Pineles; Patricia A Resick
Journal:  J Consult Clin Psychol       Date:  2012-10-15

Review 9.  Prevalence estimates of combat-related post-traumatic stress disorder: critical review.

Authors:  Lisa K Richardson; B Christopher Frueh; Ronald Acierno
Journal:  Aust N Z J Psychiatry       Date:  2010-01       Impact factor: 5.744

Review 10.  Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations.

Authors:  Janine D Flory; Rachel Yehuda
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

View more
  3 in total

1.  Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series.

Authors:  Hewa Artin; Sean Bentley; Eamonn Mehaffey; Fred X Liu; Kevin Sojourner; Andrew W Bismark; David Printz; Ellen E Lee; Brian Martis; Sharon De Peralta; Dewleen G Baker; Jyoti Mishra; Dhakshin Ramanathan
Journal:  EClinicalMedicine       Date:  2022-05-06

2.  Risk and protective factors for post-traumatic stress among New Zealand military personnel: A cross sectional study.

Authors:  Amy Richardson; Gagan Gurung; Ari Samaranayaka; Dianne Gardner; Brandon deGraaf; Emma H Wyeth; Sarah Derrett; Daniel Shepherd; David McBride
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

3.  Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder.

Authors:  Fuquan Zhang; Shuquan Rao; Hongbao Cao; Xiangrong Zhang; Qiang Wang; Yong Xu; Jing Sun; Chun Wang; Jiu Chen; Xijia Xu; Ning Zhang; Lin Tian; Jianmin Yuan; Guoqiang Wang; Lei Cai; Mingqing Xu; Ancha Baranova
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.